Stay updated on Pembrolizumab in mHSPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in mHSPC Clinical Trial page.
Latest updates to the Pembrolizumab in mHSPC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies the site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%
- Check21 days agoChange DetectedA notice explains that NIH websites are transitioning to use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), and directs visitors to updates and FAQs.SummaryDifference0.6%
- Check28 days agoChange DetectedThe footer release label changes from v3.7.1 to v3.7.2; the study record content remains unchanged.SummaryDifference0.1%
- Check35 days agoChange DetectedThe footer’s ClinicalTrials.gov revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%
- Check56 days agoChange DetectedThe study history now shows a new revision entry, changing the record from v3.6.6 to v3.7.0. This indicates the study record has been updated in its version history.SummaryDifference0.1%
- Check70 days agoChange DetectedNew sections such as Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Eligibility, Arms and Interventions, Study Description, and Study Status were added to the study record history on 2026-09-02. The 2025-10-01 entry was removed from the history.SummaryDifference1%
Stay in the know with updates to Pembrolizumab in mHSPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in mHSPC Clinical Trial page.